TickerFactsScreenerDevelopers

GYRE THERAPEUTICS, INC. (GYRE) — Shareholders' Equity

Annual figures by fiscal year, from SEC filings.

2008: $57.37M2009: $68.99M2010: $91.85M2011: $174.29M2012: -$93.34M2013: -$103.01M2014: -$109.35M2015: $31.43M2016: $16.07M2017: $30.77M2018: $119.94M2019: $68.34M2020: $76.07M2021: $41.09M2022: $42.52M2023: -$15.83M2024: $63.32M2025: $106.03M$106.03M
2008Shareholders' Equity (USD)2025
Fiscal YearShareholders' EquityChange YoY
2025$106.03M+67.5%
2024$63.32M+500.0%
2023-$15.83M-137.2%
2022$42.52M+3.5%
2021$41.09M-46.0%
2020$76.07M+11.3%
2019$68.34M-43.0%
2018$119.94M+289.8%
2017$30.77M+91.5%
2016$16.07M-48.9%
2015$31.43M+128.7%
2014-$109.35M-6.2%
2013-$103.01M-10.4%
2012-$93.34M-153.6%
2011$174.29M+89.8%
2010$91.85M+33.1%
2009$68.99M+20.2%
2008$57.37M—